Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Thrombosis and Haemostasis
DOI: 10.1160/th10-10-0679
Authors: Ola Dahl, Michael Huo, Andreas Kurth, Stefan Hantel, Karin Hermansson, Janet Schnee, Richard Friedman, Bengt Eriksson, for the RE-NOVATE II Study Group
Institutions: Thrombosis Research Institute, The University of Texas Southwestern Medical Center, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Boehringer Ingelheim (Germany), Boehringer Ingelheim (Sweden), Boehringer Ingelheim (United States), Medical University of South Carolina, Sahlgrenska University Hospital, University of Gothenburg
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Daiichi-Sankyo, Daiichi Sankyo Europe
OpenAlex ID: W1860620208
